Prevention and Early Detection

All Items

• Fine needle aspiration cytology including the analysis of human papilloma virus (HPV) DNA enhances the diagnostic workup of solitary cystic neck lesions in a population with a high incidence of HPV positive oropharyngeal cancer

  Evelina Jörtsö, Linda Marklund, Martin Harper Hysek, Anders Näsman, Lalle Hammarstedt-Nordenvall, Mathias von Beckerath, Tina Dalianis, Rusana Bark

  276-283

• Circulating tumor DNA for surveillance in high-risk melanoma patients: a study protocol

  Magnús P.B. Obinah, Sarah A. Al-Halafi, Karin Dreisig, Tim S. Poulsen, Christoffer Johansen, Thomas Litman, Stig E. Bojesen, Estrid Høgdall, Annette H. Chakera, Lisbet R. Hölmich

  229-233

• Relapse detection in the Danish surveillance program of patients with clinical stage I seminoma: a nationwide study

  Niklas B. Lindahl, Jakob Lauritsen, Thomas Wagner, Gedske Daugaard, Mikkel Bandak

  191-199

• Lynch syndrome screening in colorectal and endometrial cancers in Iceland

  Katla R. Kluvers, Thordur Tryggvason, Vigdis Stefansdottir, Jon G. Jonasson, Petur Snaebjornsson, Sigurdis Haraldsdottir

  188-190

• Adherence to guidelines for incidental pulmonary nodules: insights from a Nordic survey

  Kirill Neumann, Janna Berg , Haseem Ashraf , Johan Isaksson , Aija Knuuttila, Morten H. Borg, Torben R. Rasmussen

  22-26

• Proportion and characteristics of screen-detected and non-screen-detected colo­rectal cancers in Germany

  Michel Hornschuch, Sarina Schwarz, Ulrike Haug

  924-931

• The risk of venous thromboembolism in adult patients with diffuse glioma: a nationwide population-based study

  Frederik R. Hovman, Frantz R. Poulsen, Steinbjørn Hansen, Rikke H. Dahlrot

  887-892

• A pilot study of AI-assisted reading of prostate MRI in Organized Prostate Cancer Testing

  Erik Thimansson, Sophia Zackrisson, Fredrik Jäderling, Max Alterbeck , Thomas Jiborn , Anders Bjartell , Jonas Wallström

  816-821

• Age-specific differences in breast cancer treatment between screen-detected and non-screen-detected breast cancers in women aged 40–74 years at diagnosis in Sweden 2008–2017

  Håkan Jonsson, Anne Andersson, Zheng Mao, Lennarth Nyström

  552-556

• Agent orange exposure and prostate cancer risk in the million veteran program

  Meghana S. Pagadala, Asona J. Lui, Allison Y. Zhong, Julie A. Lynch, Roshan Karunamuni, Kyung Min Lee, Anna Plym, Brent S. Rose, Hannah K. Carter, Adam S. Kibel, Scott L. DuVall, J. Michael Gaziano, Matthew S. Panizzon, Richard L. Hauger, Tyler M. Seibert

  373-378

• Area-based disparities in non-small-cell lung cancer survival

  Nelly-Maria Paakkola, Antti Jekunen, Eero Sihvo, Mikael Johansson, Heidi Andersén

  146-153